Greater Trochanter Epiphysiodesis In Hip Pathology

Outcomes of The Greater Trochanter Epiphysiodesis In Treatment Of Children With Hip Pathology

One of the most common problems in the treatment of pediatric patients with various disorders of the hip joint is the formation of deformity of the proximal femur, such as abnormal growth of the greater trochanter, which causes it to be positioned high in relation to the femoral head. This condition is called "relative overgrowth of the greater trochanter" (ROGT).

Study Overview

• Status: Not yet recruiting
• Conditions: Orthopedic Disorder
• Intervention / Treatment: Procedure: Greater Trochanter epiphysiodesis

• Study Type: Observational
• Enrollment (Anticipated): 20

Contacts and Locations

• Study Contact: Name: Muhammed Yasser, MD; Phone Number: 0201061303076; Email: docmuhammed1@gmail.com
• Study Contact Backup: Name: Amer Alkott, MD; Phone Number: 01002329851; Email: amerabomosab@yahoo.com

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 5 years to 10 years (CHILD)
• Accepts Healthy Volunteers: N/A
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

The patients come to the outpatient clinic and underwent clinical and radiological examination will be done , then preparation to surgery by screw

Description

Inclusion Criteria:

• emerging deformities of the proximal femur with a high position of the greater trochanter, in which its apex was located above the center of the femoral head but below its superior pole; changes in the structure of the femoral neck, accompanied by its shortening; functioning growth zone of the greater trochanter at the time of intervention; and patients without surgical treatment history

Exclusion Criteria:

• hip dislocation upon examination; patients with varus deformity of the femoral neck (neck-shaft angle <120°), patients with complications of surgical interventions, trauma, rickets, and rheumatoid arthritis; and patients with neurological disorders and Refusal to participate in this study

Study Plan

How is the study designed?

Number of groups / cohorts

1

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
GT overgrowth group; pediatric patients with greater trochanter overgrowth	Procedure: Greater Trochanter epiphysiodesis; epiphysiodesis by cortical screw and washer

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Radiological measurments	articulo-trochanteric distance	12 month

Collaborators and Investigators

• Sponsor: Al-Azhar University

Publications and helpful links

General Publications

• McCarthy JJ, Weiner DS. Greater trochanteric epiphysiodesis. Int Orthop. 2008 Aug;32(4):531-4. doi: 10.1007/s00264-007-0346-5. Epub 2007 Mar 10.

Study record dates

Study Major Dates

• Study Start (ANTICIPATED): January 1, 2022
• Primary Completion (ANTICIPATED): January 1, 2023
• Study Completion (ANTICIPATED): January 1, 2024

Study Registration Dates

• First Submitted: January 4, 2022
• First Submitted That Met QC Criteria: January 4, 2022
• First Posted (ACTUAL): January 18, 2022

Study Record Updates

• Last Update Posted (ACTUAL): January 18, 2022
• Last Update Submitted That Met QC Criteria: January 4, 2022
• Last Verified: January 1, 2022

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Musculoskeletal Diseases
• Other Study ID Numbers: GTE

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No